Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

The NEO-FFI domain of openness to experience moderates ketamine response in treatment resistant depression.

Dale RM, Bryant KA, Finnegan N, Cromer K, Thompson NR, Altinay M, Anand A.

J Affect Disord. 2019 Sep 3;260:323-328. doi: 10.1016/j.jad.2019.09.010. [Epub ahead of print]

PMID:
31521869
2.

Upper Airway Stimulation vs Positive Airway Pressure Impact on BP and Sleepiness Symptoms in OSA.

Walia HK, Thompson NR, Strohl KP, Faulx MD, Waters T, Kominsky A, Foldvary-Schaefer N, Mehra R.

Chest. 2019 Jul 9. pii: S0012-3692(19)31313-3. doi: 10.1016/j.chest.2019.06.020. [Epub ahead of print]

PMID:
31299245
3.

Predictors of favorable quality of life outcome following kyphoplasty and vertebroplasty.

Jones JC, Miller JA, Sudarshana DM, Thompson NR, Benzel EC, Mroz TE.

J Neurosurg Spine. 2019 May 24:1-8. doi: 10.3171/2019.3.SPINE18419. [Epub ahead of print]

PMID:
31125962
4.

Association Between Patient Experience With Patient-Reported Outcome Measurements and Overall Satisfaction With Care in Neurology.

Lapin BR, Honomichl RD, Thompson NR, Rose S, Sugano D, Udeh B, Katzan IL.

Value Health. 2019 May;22(5):555-563. doi: 10.1016/j.jval.2019.02.007.

PMID:
31104734
5.

Understanding quality of life and treatment history of patients with Bertolotti syndrome compared with lumbosacral radiculopathy.

Golubovsky JL, Momin A, Thompson NR, Steinmetz MP.

J Neurosurg Spine. 2019 Apr 19:1-7. doi: 10.3171/2019.2.SPINE1953. [Epub ahead of print]

PMID:
31003219
6.

Corrigendum to "Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60" [Multiple Sclerosis and Related Disorders 30 (2019) 252-256].

Hua LH, Harris H, Conway D, Thompson NR.

Mult Scler Relat Disord. 2019 May;30:293. doi: 10.1016/j.msard.2019.03.013. Epub 2019 Mar 26. No abstract available.

PMID:
30987754
7.

Quality of life outcomes in patients presenting for evaluation of CNS tumors.

Chaitoff A, Sarmey N, Thompson NR, Fan Y, Ahluwalia M, Katzan IL.

Neurol Clin Pract. 2019 Feb;9(1):32-40. doi: 10.1212/CPJ.0000000000000571.

PMID:
30859005
8.

Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60.

Hua LH, Harris H, Conway D, Thompson NR.

Mult Scler Relat Disord. 2019 May;30:252-256. doi: 10.1016/j.msard.2019.02.028. Epub 2019 Mar 1. Erratum in: Mult Scler Relat Disord. 2019 May;30:293.

PMID:
30851638
9.

Patient versus proxy response on global health scales: no meaningful DIFference.

Lapin BR, Thompson NR, Schuster A, Katzan IL.

Qual Life Res. 2019 Jun;28(6):1585-1594. doi: 10.1007/s11136-019-02130-y. Epub 2019 Feb 13.

PMID:
30759300
10.

Prognostic factors of disability in relapsing remitting multiple sclerosis.

Briggs FBS, Thompson NR, Conway DS.

Mult Scler Relat Disord. 2019 May;30:9-16. doi: 10.1016/j.msard.2019.01.045. Epub 2019 Jan 29.

PMID:
30711764
11.

Clinical Utility of Patient-Reported Outcome Measurement Information System Domain Scales.

Lapin B, Thompson NR, Schuster A, Katzan IL.

Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004753. doi: 10.1161/CIRCOUTCOMES.118.004753.

PMID:
30587028
12.

Accuracy of Linking VR-12 and PROMIS Global Health Scores in Clinical Practice.

Lapin BR, Kinzy TG, Thompson NR, Krishnaney A, Katzan IL.

Value Health. 2018 Oct;21(10):1226-1233. doi: 10.1016/j.jval.2018.03.011. Epub 2018 Apr 26.

PMID:
30314624
13.

The Impact of Infection and Elevated INR in LVAD-Associated Intracranial Hemorrhage: A Case-Crossover Study.

Cho SM, Lee T, Starling RC, Thompson NR, Uchino K.

ASAIO J. 2019 Aug;65(6):545-549. doi: 10.1097/MAT.0000000000000887.

PMID:
30312211
14.

The use of STarT back screening tool to predict functional disability outcomes in patients receiving physical therapy for low back pain.

Katzan IL, Thompson NR, George SZ, Passek S, Frost F, Stilphen M.

Spine J. 2019 Apr;19(4):645-654. doi: 10.1016/j.spinee.2018.10.002. Epub 2018 Oct 9.

PMID:
30308254
15.

Cerebral ischemia and deterioration with lower blood pressure target in intracerebral hemorrhage.

Buletko AB, Thacker T, Cho SM, Mathew J, Thompson NR, Organek N, Frontera JA, Uchino K.

Neurology. 2018 Sep 11;91(11):e1058-e1066. doi: 10.1212/WNL.0000000000006156. Epub 2018 Aug 10.

PMID:
30097480
16.

Patient-Reported Disease-Modifying Therapy Adherence in the Clinic: A Reliable Metric?

Conway DS, Cecilia Vieira M, Thompson NR, Parker KN, Meng X, Fox RJ.

Mult Scler J Exp Transl Clin. 2018 May 23;4(2):2055217318777894. doi: 10.1177/2055217318777894. eCollection 2018 Apr-Jun.

17.

Neurologic provider views on patient-reported outcomes including depression screening.

Katzan IL, Thompson NR, Dunphy C, Urchek J, Lapin B.

Neurol Clin Pract. 2018 Apr;8(2):86-92. doi: 10.1212/CPJ.0000000000000438.

18.

Letter by Lapin et al Regarding Article, "PROMIS GH (Patient-Reported Outcomes Measurement Information System Global Health) Scale in Stroke: A Validation Study".

Lapin B, Thompson NR, Katzan IL.

Stroke. 2018 May;49(5):e214. doi: 10.1161/STROKEAHA.118.021483. Epub 2018 Apr 4. No abstract available.

PMID:
29618554
19.

The most affected health domains after ischemic stroke.

Katzan IL, Thompson NR, Uchino K, Lapin B.

Neurology. 2018 Apr 17;90(16):e1364-e1371. doi: 10.1212/WNL.0000000000005327. Epub 2018 Mar 28.

PMID:
29592886
20.

Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological Institute.

Viguera AC, Fan Y, Thompson NR, Lapin B, Chaitoff A, Griffith SD, Miller DM, Jehi L, Katzan IL.

Psychosomatics. 2018 Jul - Aug;59(4):369-378. doi: 10.1016/j.psym.2017.12.003. Epub 2017 Dec 13.

PMID:
29580558
21.

Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.

Achey RL, Yamamoto E, Sexton D, Hammer C, Lee BS, Butler RS, Thompson NR, Nagel SJ, Machado AG, Lobel DA.

J Neurosurg. 2018 Dec 1;129(6):1562-1571. doi: 10.3171/2017.8.JNS1733.

PMID:
29473781
22.

Depression score changes in response to sleep disordered breathing treatment with positive airway pressure in a large clinic-based cohort.

Relia S, Thompson NR, Mehra R, Moul D, Katzan I, Foldvary-Schaefer N, Walia HK.

Sleep Breath. 2018 Mar;22(1):195-203. doi: 10.1007/s11325-018-1626-6. Epub 2018 Jan 29.

PMID:
29380097
23.

Cost Analysis of the Addition of Hyperacute Magnetic Resonance Imaging for Selection of Patients for Endovascular Stroke Therapy.

John S, Thompson NR, Lesko T, Papesh N, Obuchowski N, Tomic D, Wisco D, Khawaja Z, Uchino K, Man S, Cheng-Ching E, Toth G, Masaryk T, Ruggieri P, Modic M, Hussain MS.

Interv Neurol. 2017 Oct;6(3-4):183-190. doi: 10.1159/000472158. Epub 2017 May 5.

24.

Minimally Clinically Important Change in the Activity Measure for Post-Acute Care (AM-PAC), a Generic Patient-Reported Outcome Tool, in People With Low Back Pain.

Lee N, Thompson NR, Passek S, Stilphen M, Katzan IL.

Phys Ther. 2017 Nov 1;97(11):1094-1102. doi: 10.1093/ptj/pzx083.

PMID:
29077945
25.

Short-wavelength free-electron laser sources and science: a review.

Seddon EA, Clarke JA, Dunning DJ, Masciovecchio C, Milne CJ, Parmigiani F, Rugg D, Spence JCH, Thompson NR, Ueda K, Vinko SM, Wark JS, Wurth W.

Rep Prog Phys. 2017 Nov;80(11):115901. doi: 10.1088/1361-6633/aa7cca.

PMID:
29059048
26.

Impact of Sleep-Disordered Breathing Treatment on Quality of Life Measures in a Large Clinic-Based Cohort.

Walia HK, Thompson NR, Katzan I, Foldvary-Schaefer N, Moul DE, Mehra R.

J Clin Sleep Med. 2017 Nov 15;13(11):1255-1263. doi: 10.5664/jcsm.6792.

27.

Scale Linking to Enable Patient-Reported Outcome Performance Measures Assessed with Different Patient-Reported Outcome Measures.

Katzan IL, Fan Y, Griffith SD, Crane PK, Thompson NR, Cella D.

Value Health. 2017 Sep;20(8):1143-1149. doi: 10.1016/j.jval.2017.05.012. Epub 2017 Jun 20.

28.

Predictors of Functional and Quality of Life Outcomes following Deep Brain Stimulation Surgery in Parkinson's Disease Patients: Disease, Patient, and Surgical Factors.

Abboud H, Genc G, Thompson NR, Oravivattanakul S, Alsallom F, Reyes D, Wilson K, Cerejo R, Yu XX, Floden D, Ahmed A, Gostkowski M, Ezzeldin A, Marouf H, Mansour OY, Machado A, Fernandez HH.

Parkinsons Dis. 2017;2017:5609163. doi: 10.1155/2017/5609163. Epub 2017 Aug 9.

29.

Evaluation of the Patient Health Questionnaire-2 as a Screening Tool for Depression during the Acute Stroke Admission.

Shankar L, Smith N, Uchino K, Thompson NR, Pozuelo L, Katzan IL.

J Stroke Cerebrovasc Dis. 2017 Nov;26(11):2519-2526. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.044. Epub 2017 Jul 26.

PMID:
28756141
30.

Added Value of Patient-Reported Outcome Measures in Stroke Clinical Practice.

Katzan IL, Thompson NR, Lapin B, Uchino K.

J Am Heart Assoc. 2017 Jul 21;6(7). pii: e005356. doi: 10.1161/JAHA.116.005356.

31.

Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.

Thompson NR, Lapin BR, Katzan IL.

Pharmacoeconomics. 2017 Nov;35(11):1167-1176. doi: 10.1007/s40273-017-0541-1.

PMID:
28710740
32.

Central Sensitization Inventory as a Predictor of Worse Quality of Life Measures and Increased Length of Stay Following Spinal Fusion.

Bennett EE, Walsh KM, Thompson NR, Krishnaney AA.

World Neurosurg. 2017 Aug;104:594-600. doi: 10.1016/j.wneu.2017.04.166. Epub 2017 May 4.

PMID:
28479522
33.

Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Correlation of Histopathology and MRI in Prion Disease.

Mente KP, O'Donnell JK, Jones SE, Cohen ML, Thompson NR, Bizzi A, Gambetti P, Safar JG, Appleby BS.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):1-7. doi: 10.1097/WAD.0000000000000188.

34.

Impact of Sleep-Disordered Breathing Treatment on Patient Reported Outcomes in a Clinic-Based Cohort of Hypertensive Patients.

Walia HK, Griffith SD, Thompson NR, Moul DE, Foldvary-Schaefer N, Mehra R.

J Clin Sleep Med. 2016 Oct 15;12(10):1357-1364.

35.

Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomes.

Conway DS, Thompson NR, Cohen JA.

Mult Scler Relat Disord. 2016 Sep;9:129-34. doi: 10.1016/j.msard.2016.07.017. Epub 2016 Jul 27.

PMID:
27645360
36.

A screening tool for obstructive sleep apnea in cerebrovascular patients.

Katzan IL, Thompson NR, Uchino K, Foldvary-Schaefer N.

Sleep Med. 2016 May;21:70-6. doi: 10.1016/j.sleep.2016.02.001. Epub 2016 Feb 20.

PMID:
27448475
37.

Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course.

Conway DS, Thompson NR, Cohen JA.

Mult Scler. 2017 Feb;23(2):277-285. doi: 10.1177/1352458516650512. Epub 2016 Jul 11.

PMID:
27230791
38.

Membrane-Stabilizing Agents Improve Quality-of-Life Outcomes for Patients with Lumbar Stenosis.

Bansal S, Lubelski D, Thompson NR, Shah AA, Mazanec DJ, Benzel EC, Khalaf T.

Global Spine J. 2016 Mar;6(2):139-46. doi: 10.1055/s-0035-1557144. Epub 2015 Jul 14.

39.

Predictors of outcomes and hospital charges following atlantoaxial fusion.

Tanenbaum JE, Lubelski D, Rosenbaum BP, Thompson NR, Benzel EC, Mroz TE.

Spine J. 2016 May;16(5):608-18. doi: 10.1016/j.spinee.2015.12.090. Epub 2016 Jan 11.

40.

Correlation of quality of life and functional outcome measures for cervical spondylotic myelopathy.

Lubelski D, Alvin MD, Nesterenko S, Sundar SJ, Thompson NR, Benzel EC, Mroz TE.

J Neurosurg Spine. 2016 Mar;24(3):483-9. doi: 10.3171/2015.6.SPINE159. Epub 2015 Nov 27.

PMID:
26613280
41.

Prediction of quality of life improvements in patients with lumbar stenosis following use of membrane stabilizing agents.

Lubelski D, Thompson NR, Agrawal B, Abdullah KG, Alvin MD, Khalaf T, Mazanec DJ, Benzel EC, Mroz TE, Krishnaney AA.

Clin Neurol Neurosurg. 2015 Dec;139:234-40. doi: 10.1016/j.clineuro.2015.10.018. Epub 2015 Oct 19.

PMID:
26519895
42.

Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.

Maasumi K, Thompson NR, Kriegler JS, Tepper SJ.

Headache. 2015 Oct;55(9):1218-24. doi: 10.1111/head.12657. Epub 2015 Sep 18. Erratum in: Headache. 2016 Feb;56(2):449.

PMID:
26381856
43.

Comparison of Electronic Screening for Suicidal Risk With the Patient Health Questionnaire Item 9 and the Columbia Suicide Severity Rating Scale in an Outpatient Psychiatric Clinic.

Viguera AC, Milano N, Laurel R, Thompson NR, Griffith SD, Baldessarini RJ, Katzan IL.

Psychosomatics. 2015 Sep-Oct;56(5):460-9. doi: 10.1016/j.psym.2015.04.005. Epub 2015 May 8.

PMID:
26278339
44.

National Incidence of Medication Error in Surgical Patients Before and After Accreditation Council for Graduate Medical Education Duty-Hour Reform.

Vadera S, Griffith SD, Rosenbaum BP, Chan AY, Thompson NR, Kshettry VR, Kelly ML, Weil RJ, Bingaman W, Jehi L.

J Surg Educ. 2015 Nov-Dec;72(6):1209-16. doi: 10.1016/j.jsurg.2015.05.013. Epub 2015 Jun 15.

PMID:
26089160
45.

Socioeconomic Status May Impact Functional Outcome of Deep Brain Stimulation Surgery in Parkinson's Disease.

Genc G, Abboud H, Oravivattanakul S, Alsallom F, Thompson NR, Cooper S, Gostkowski M, Machado A, Fernandez HH.

Neuromodulation. 2016 Jan;19(1):25-30. doi: 10.1111/ner.12324. Epub 2015 Jun 15.

PMID:
26076401
46.

A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality.

Thompson NR, Fan Y, Dalton JE, Jehi L, Rosenbaum BP, Vadera S, Griffith SD.

Med Care. 2015 Apr;53(4):374-9. doi: 10.1097/MLR.0000000000000326.

47.

Reoperation rates after anterior cervical discectomy and fusion versus posterior cervical foraminotomy: a propensity-matched analysis.

Lubelski D, Healy AT, Silverstein MP, Abdullah KG, Thompson NR, Riew KD, Steinmetz MP, Benzel EC, Mroz TE.

Spine J. 2015 Jun 1;15(6):1277-83. doi: 10.1016/j.spinee.2015.02.026. Epub 2015 Feb 23.

PMID:
25720729
48.

Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center.

Dickstein LP, Viguera AC, Nowacki AS, Thompson NR, Griffith SD, Baldessarini RJ, Katzan IL.

Psychosomatics. 2015 Jan-Feb;56(1):44-51. doi: 10.1016/j.psym.2014.05.008. Epub 2014 Jun 5.

PMID:
25619673
49.

Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease.

Abboud H, Floden D, Thompson NR, Genc G, Oravivattanakul S, Alsallom F, Swa B, Kubu C, Pandya M, Gostkowski M, Cooper S, Machado AG, Fernandez HH.

Parkinsonism Relat Disord. 2015 Mar;21(3):249-53. doi: 10.1016/j.parkreldis.2014.12.018. Epub 2014 Dec 31.

PMID:
25578289
50.

Depression as a predictor of worse quality of life outcomes following nonoperative treatment for lumbar stenosis.

Lubelski D, Thompson NR, Bansal S, Mroz TE, Mazanec DJ, Benzel EC, Khalaf T.

J Neurosurg Spine. 2015 Mar;22(3):267-72. doi: 10.3171/2014.10.SPINE14220. Epub 2014 Dec 19.

PMID:
25525957

Supplemental Content

Loading ...
Support Center